(Q38461768)

3 September 2017

title

SSA-MOA: a novel CTC isolation platform using selective size amplification (SSA) and a multi-obstacle architecture (MOA) filter (English)

1 reference

3 September 2017

Minseok S Kim

1

1 reference

3 September 2017

Tae Seok Sim

2

1 reference

3 September 2017

Yeon Jeong Kim

3

1 reference

3 September 2017

Sun Soo Kim

4

1 reference

3 September 2017

Hyoyoung Jeong

5

1 reference

3 September 2017

Jong-Myeon Park

6

1 reference

3 September 2017

Hui-Sung Moon

7

1 reference

3 September 2017

Seung Il Kim

8

1 reference

3 September 2017

Ogan Gurel

9

1 reference

3 September 2017

Soo Suk Lee

10

1 reference

3 September 2017

Jeong-Gun Lee

11

1 reference

3 September 2017

Jae Chan Park

12

1 reference

3 September 2017

publication date

11 June 2012

1 reference

3 September 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

Lab on a Chip

1 reference

3 September 2017

volume

12

1 reference

3 September 2017

issue

16

1 reference

3 September 2017

page(s)

2874-2880

1 reference

Detection, clinical relevance and specific biological properties of disseminating tumour cells

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC2LC40065K

Circulating tumor cells (CTC) detection: clinical impact and future directions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2LC40065K

21 January 2018

Circulating cancer cells

1 reference

https://api.crossref.org/works/10.1039%2FC2LC40065K

Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2LC40065K

Optimal markers for real-time quantitative reverse transcription PCR detection of circulating tumor cells from melanoma, breast, colon, esophageal, head and neck, and lung cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2LC40065K

Isolation of rare circulating tumour cells in cancer patients by microchip technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2LC40065K

Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2LC40065K

Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2LC40065K

Detection and characterization of circulating and disseminated prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2LC40065K

Isolation by size of epithelial tumor cells : a new method for the immunomorphological and molecular characterization of circulatingtumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2LC40065K

Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2LC40065K

Isolation of tumor cells using size and deformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2LC40065K

Microdevice for the isolation and enumeration of cancer cells from blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2LC40065K

Size-selective microcavity array for rapid and efficient detection of circulating tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2LC40065K

Isolation of rare cells from cell mixtures by dielectrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2LC40065K

Case study of the morphologic variation of circulating tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2LC40065K

Circulating tumor cells: approaches to isolation and characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2LC40065K

Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2LC40065K

Cell docking and on-chip monitoring of cellular reactions with a controlled concentration gradient on a microfluidic device

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2LC40065K

Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2LC40065K

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2LC40065K

Circulating tumor cells in breast cancer: Advanced tools for "tailored" therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2LC40065K

Cell filtration‐laser scanning cytometry for the characterisation of circulating breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2LC40065K

Isolation of circulating tumor cells using a microvortex-generating herringbone-chip

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2LC40065K

21 January 2018

Identifiers

DOI

10.1039/C2LC40065K

1 reference

3 September 2017

1 reference